bso glutathione depletion Buthionine sulfoximine, an inhibitor of biosynthesis, induces expression of soluble epoxide hydrolase and resistant human breast cancer cells Sigma-Aldrich ᴅʟ-Buthionine-sulfoximine, CAS 5072-26-4, ≥99.0%
Sigma Aldrich Buthionine sulfoximine, CAS 5072 26 4, 99.0% (TLC) 250 mg Glutathione metabolismrelated proteins expression in BSOtreated Download Scientific Diagram Lowering glutathione level by buthionine sulfoximine enhances in vivo photodynamic therapy using chlorin e6 loaded nanoparticles ScienceDirect Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma ScienceDirect
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



